Updates on Urologic Oncology: From Diagnosis to Localized and Systemic Therapy Options

Dear Colleagues,

Urological malignancies are one of the leading causes of cancer-related death worldwide. The early and accurate diagnosis of these neoplasms can enable the more effective and personalized management of the affected patients. Liquid biopsy is adopting an increasingly prominent role in the diagnosis and prognosis of bladder and prostate cancer. New prognostic biomarkers are currently being studied in the context of renal cancer management. Moreover, the new minimally invasive surgical technologies enable the constant improvement of patients’ oncological and functional outcomes, just as immunotherapy represents a significant advance in the evolution of the treatment of major urological neoplasms, both localized and locally advanced. The purpose of this Special Issue is to summarize the latest innovations in the diagnostic and therapeutic management of urological neoplasms and the future perspectives that may be derived from current research.

Dr. Giuseppe Palermo
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.